Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
•
Pediatric Hematology/Oncology
How would you treat a skull based chordoma in a pediatric patient?
If proton therapy is not available would you consider radiosurgery?
How would your management differ if residual disease is present?
Related Questions
How do you counsel patients with locally advanced malignancies who have ECOG 3-4?
In a patient with history of successfully treated locally advanced H&N cancer, how do you discern between a metachronous second primary locally advanced lung SCC vs. metastatic head and neck SCC?
For patients with recurrence or second primary in the head and neck after prior radiation, what would be the postoperative indications for adjuvant radiation?
What special considerations do you take when treating cancer patients with severe intellectual disabilities?
How would you approach SCC of unknown primary, p16-, EBV-, metastatic to a large 5.5 cm level 2 neck node, if you suspect a cutaneous origin after clinical workup?
Are any centers routinely using 55 Gy in 20 fractions with chemotherapy for definitive treatment of head and neck cancer following presentation of the HYPNO study?
What is your approach to reporting mandible dose received to the dentist/oral surgeon?
Do you recommend radioactive iodine for Hürthle Cell thyroid carcinoma?
How do you counsel patients and partners of patients with HPV+ cancers regarding the HPV vaccine?
What is your radiation dose/volume for adjuvant treatment of a clear cell odontogenic carcinoma of the mandible after segmental resection?